Clinical features of seizures in patients with human immunodeficiency virus infection

J Korean Med Sci. 2015 Jun;30(6):694-9. doi: 10.3346/jkms.2015.30.6.694. Epub 2015 May 13.

Abstract

Patients with human immunodeficiency virus (HIV) infection have a higher burden of seizures, but few studies have examined seizures in HIV-infected individuals in Korea. A retrospective study was conducted to determine the epidemiology and clinical characteristics of seizures in patients with HIV infection. Among a total of 1,141 patients, 34 (3%) had seizures or epilepsy; 4 of these individuals had epilepsy before HIV infection, and the others showed new-onset seizures. Most patients exhibited moderate (200 to 500, n = 13) or low (below 200, n = 16) CD4 counts. The most common seizure etiology was progressive multifocal leukoencephalopathy (n = 14), followed by other HIV-associated central nervous system (CNS) complications (n = 6). Imaging studies revealed brain lesions in 21 patients. A total of 9 patients experienced only one seizure during the follow-up period, and 25 patients experienced multiple seizures or status epilepticus (n = 2). Multiple seizures were more common in patients with brain etiologies (P = 0.019) or epileptiform discharges on EEG (P = 0.032). Most seizures were controlled without anticonvulsants (n = 12) or with a single anticonvulsant (n = 12). Among patients with HIV infection, seizures are significantly more prevalent than in the general population. Most seizures, with the exception of status epilepticus, have a benign clinical course and few complications.

Keywords: HIV; Korea; Seizures.

MeSH terms

  • Adult
  • Aged
  • Anticonvulsants / therapeutic use
  • Causality
  • Comorbidity
  • Electroencephalography / statistics & numerical data*
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology*
  • Humans
  • Incidence
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Republic of Korea / epidemiology
  • Risk Factors
  • Seizures / diagnosis*
  • Seizures / epidemiology*
  • Seizures / prevention & control
  • Treatment Outcome

Substances

  • Anticonvulsants